{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-Gram-Positive Lefamulin",
        "VITEK\u00ae 2 AST-GP Lefamulin"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K234000",
    "Predicate Device Reference 510(k) Number(s)": [
        "K230864"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTT",
        "LTW"
    ],
    "Summary Letter Date": "December 15, 2023",
    "Summary Letter Received Date": "December 18, 2023",
    "Submission Date": "December 15, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Lefamulin"
    ],
    "Specimen Type(s)": [
        "Gram-positive microorganisms",
        "Bacterial isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility testing",
        "Microdilution minimum inhibitory concentration (MIC)"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Microdilution MIC"
    ],
    "Submission Type(s)": [
        "Susceptibility card",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-Gram-Positive Lefamulin susceptibility card for automated MIC determination of Gram-positive bacteria.",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of Gram-positive microorganisms as a laboratory aid to determine in vitro susceptibility to Lefamulin using VITEK 2 and VITEK 2 Compact Systems.",
    "fda_folder": "Microbiology"
}